Last reviewed · How we verify
F# 13418-148 Eye Drops — Competitive Intelligence Brief
phase 3
Ophthalmology
Small molecule
Live · refreshed every 30 min
Target snapshot
F# 13418-148 Eye Drops (F# 13418-148 Eye Drops) — Johnson & Johnson Consumer Inc. (J&JCI). F# 13418-148 is an ophthalmic formulation designed to treat dry eye disease by lubricating and protecting the ocular surface.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| F# 13418-148 Eye Drops TARGET | F# 13418-148 Eye Drops | Johnson & Johnson Consumer Inc. (J&JCI) | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- F# 13418-148 Eye Drops CI watch — RSS
- F# 13418-148 Eye Drops CI watch — Atom
- F# 13418-148 Eye Drops CI watch — JSON
- F# 13418-148 Eye Drops alone — RSS
Cite this brief
Drug Landscape (2026). F# 13418-148 Eye Drops — Competitive Intelligence Brief. https://druglandscape.com/ci/f-13418-148-eye-drops. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab